Pain News and Research

Latest Pain News and Research

New Orthopaedic & Spine Center guide discusses conservative treatment options for hip, knee and spine pain

The physicians at Orthopaedic & Spine Center have put together an information guide – Surgery Isn't Always the Answer. The resource discusses conservative treatment options for those who suffer from hip, knee, and spine pain. The guide also shares information on the benefits of early diagnosis and minimally-invasive surgical treatments.

31 Mar 2015

ITOCHU CHEMICAL FRONTIER makes strategic investment in SCILEX Pharmaceuticals

SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced that ITOCHU CHEMICAL FRONTIER Corporation (ICF, Tokyo Japan), a member of ITOCHU Corporation, one of the three leading sogo shosha (general trading companies) in Japan, has made a strategic investment in SCILEX.

31 Mar 2015

MOVANTIK (naloxegol) now available in U.S. for treatment of OIC in adult patients with non-cancer pain

Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.

31 Mar 2015

Study provides new estimates of opioid misuse, addiction

New estimates suggest that 20 to 30 percent of opioid analgesic drugs prescribed for chronic pain are misused, while the rate of opioid addiction is approximately 10 percent, reports a study in the April issue of PAIN, the official journal of the International Association for the Study of Pain.

31 Mar 2015

Minimally invasive laparoscopic surgery significantly lowers health care costs

Adding to the clinical benefits and improved patient outcomes associated with minimally invasive surgery, Medtronic highlighted a study published in the March 25 online edition of JAMA Surgery. The new study demonstrated that patients who underwent laparoscopic colectomy procedures required fewer days of health care utilization and the health care system spent less on their acute and follow-up care than those who underwent traditional open surgery.

31 Mar 2015

Ultrasound safer than other imaging modalities for imaging female pelvis, say OB/GYN experts

Ultrasound technology has evolved dramatically in recent years. A group of noted obstetricians and gynecologists maintain that ultrasound is more cost-effective and safer than other imaging modalities for imaging the female pelvis and should be the first imaging modality used for patients with pelvic symptoms.

31 Mar 2015

Breast ultrasound examination may eliminate need for biopsy in teens with breast lumps

If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. However, breast cancer is rare in adolescents, and the vast majority of teenage breast lumps turn out to be benign masses that are related to hormones and often go away over time.

31 Mar 2015

Higher levels of vitamin D decrease pain, improve function in obese patients with osteoarthritis

Got milk? If you are overweight and have osteoarthritis, you may want to bone up on your dairy products that have vitamin D.

31 Mar 2015

Useful tips for physicians to help patients make the right choice on statin drugs

Cholesterol-lowering statins have transformed the treatment of heart disease. But while the decision to use the drugs in patients with a history of heart attacks and strokes is mostly clear-cut, that choice can be a far trickier proposition for the tens of millions of Americans with high cholesterol but no overt disease.

31 Mar 2015

Investigational S-equol nutritional supplement may alleviate certain menopause symptoms

The investigational S-equol nutritional supplement may be a viable agent to alleviate certain menopause symptoms, such as hot flashes, according to a new peer-reviewed article in the March Journal of Women's Health.

30 Mar 2015

DURECT initiates DUR-928 multi-dose Phase 1 clinical trial for NAFLD, NASH and AKI

DURECT Corporation today announced that it has initiated a multi-dose Phase 1 clinical trial of an oral formulation of DUR-928, the lead molecule in DURECT's Epigenomic Regulator Program.

30 Mar 2015

$Two surgical methods safe, effective for healing distal femur fractures$

Two surgical methods safe, effective for healing distal femur fractures

A team of orthopedic surgeons from the Perelman School of Medicine at the University of Pennsylvania has found that modern technology for healing distal femur fractures is as safe and effective as its more established alternative, without a potential shortfall of the older approach.

30 Mar 2015

Clonidine Topical Gel fails to meet primary endpoint in Phase 3 study for treatment of painful diabetic neuropathy

BioDelivery Sciences International, Inc. announced that the primary efficacy endpoint in the Phase 3 clinical study of Clonidine Topical Gel compared to placebo for the treatment of painful diabetic neuropathy did not meet statistical significance, although certain secondary endpoints showed statistically significant improvement over placebo. In addition, a strong safety profile for the product was observed.

30 Mar 2015

Two scientific studies may change clinical practices regarding medical abortions, miscarriages

Two scientific studies led by researchers at Sweden's Karolinska Institutet are expected to form the basis of new international recommendations for the treatment of medical abortions and miscarriages.

30 Mar 2015

$FLS could reduce healthcare costs associated with osteoporotic fractures$

FLS could reduce healthcare costs associated with osteoporotic fractures

Using a simulation model, Swedish researchers have shown that the implementation of Fracture Liaison Services (FLS) could considerably reduce the human and healthcare costs associated with osteoporotic fractures. The results from the model were presented today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Milan.

30 Mar 2015

Naldemedine meets primary and secondary endpoints in phase III study for OIC treatment

Naldemedine, an investigational peripherally acting mu-opioid receptor antagonist (PAMORA) under development by Shionogi & Co., Ltd., met its primary and secondary endpoints in a phase III study (COMPOSE I) for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain receiving opioid therapy.

30 Mar 2015

Pain relief from IA injection may not predict better outcomes following arthroscopic hip surgery

How best to treat and recover from complicated hip injuries is a growing field in orthopaedic medicine. While diagnostic hip injections are commonly performed for patients with labral tear to confirm the pain etiology, research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day suggests that pain relief from this diagnostic injection may not predict better outcomes following arthroscopic hip surgery.

30 Mar 2015

Study demonstrates abnormal vitamin D levels in more than one-third of elite NCAA Division I athletes

A new study presented today at the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons found that more than one-third of elite, Division I college athletes may have low levels of vitamin D, which is critical in helping the body to absorb calcium needed to maintain bone mass, and to minimize musculoskeletal pain and injury risk.

30 Mar 2015

Combination treatment improves outcomes in women with ovarian cancer

Medical researchers are always looking for ways to prevent or cure cancer. Given the complexity of this disease, reaching these milestones has been difficult.

30 Mar 2015

Penn State surgeon provides guidelines for diagnosis, management of endometriosis

Endometriosis is difficult to diagnose, with women often being told for years that they are experiencing their 'normal period.' According to the Endometriosis Foundation of America, it affects one in ten women.

30 Mar 2015

Pain News and Research

Latest Pain News and Research

New Orthopaedic & Spine Center guide discusses conservative treatment options for hip, knee and spine pain

ITOCHU CHEMICAL FRONTIER makes strategic investment in SCILEX Pharmaceuticals

MOVANTIK (naloxegol) now available in U.S. for treatment of OIC in adult patients with non-cancer pain

Study provides new estimates of opioid misuse, addiction

Minimally invasive laparoscopic surgery significantly lowers health care costs

Ultrasound safer than other imaging modalities for imaging female pelvis, say OB/GYN experts

Breast ultrasound examination may eliminate need for biopsy in teens with breast lumps

Higher levels of vitamin D decrease pain, improve function in obese patients with osteoarthritis

Useful tips for physicians to help patients make the right choice on statin drugs

Investigational S-equol nutritional supplement may alleviate certain menopause symptoms

DURECT initiates DUR-928 multi-dose Phase 1 clinical trial for NAFLD, NASH and AKI

Two surgical methods safe, effective for healing distal femur fractures

Clonidine Topical Gel fails to meet primary endpoint in Phase 3 study for treatment of painful diabetic neuropathy

Two scientific studies may change clinical practices regarding medical abortions, miscarriages

FLS could reduce healthcare costs associated with osteoporotic fractures

Naldemedine meets primary and secondary endpoints in phase III study for OIC treatment

Pain relief from IA injection may not predict better outcomes following arthroscopic hip surgery

Study demonstrates abnormal vitamin D levels in more than one-third of elite NCAA Division I athletes

Combination treatment improves outcomes in women with ovarian cancer

Penn State surgeon provides guidelines for diagnosis, management of endometriosis

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Pain News and Research

Latest Pain News and Research

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in